Experimenting with mice, Johns Hopkins researchers report they have successfully used positron emission tomography (PET) scans to calculate in real time how much of an immunotherapy drug reaches a tumor and what parts of a cancer remain unaffected. {read more here}

A new study of PET scans has identified a biomarker that may accurately predict which patients with one type of HER2-positive breast cancer might best benefit from standalone HER2-targeted agents, without the need for standard chemotherapy. {read more here}

Should coronary artery calcium (CAC) scoring be a routine part of PET/CT stress testing for assessing an individual’s risk of heart disease? Yes, according to researchers from Utah who explained why in a Saturday presentation at the American College of Cardiology (ACC) 2019 meeting in New Orleans. {read more here}

Whole-body PET/CT with the standard radiotracer 18F-FDG is a dependable screening tool for catching many metastases, distant as well as regional lymphatic, according to researchers at the University of Minnesota. {read more here}